| Filed On | Filing |
|---|---|
| 23 Jun 2026 |
8-K/A: Financial Statements and Exhibits
This Asset Purchase Agreement, dated as of June 22, 2026 (this “Agreement”), is made by and among (i) Sangamo Therapeutics, Inc., a Delaware corporation (“Seller”), (ii) Merope Acquisition Sub, LLC, a Delaware limited liability company a... |
| 27 May 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 18 Jun 2020 | 8-K/A: Financial Statements and Exhibits |
| 07 Jan 2019 | 8-K/A: Financial Statements and Exhibits |
| 27 Apr 2018 | 8-K/A: Financial Statements and Exhibits |
| 09 Dec 2013 | 8-K/A: Financial Statements and Exhibits |
| 19 Oct 2011 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 05 Nov 2003 | 8-K/A: Results of Operations and Financial Condition |
| 17 Aug 2001 | 8-K/A: Completion of Acquisition or Disposition of Assets |
Loading...
